1)杉浦真弓 : エビデンスに基づいた不育症・習慣流産の診療.金芳堂,2017
2)Sugiura-Ogasawara M, et al : Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod 27 : 2297─2303, 2012
3)Miyakis S, et al : International consensus statement of an update of the classification criteria for definite antiphospholipid syndrome(APS). J Thromb Haemost 4 : 295─306. 2006
4)Ruiz-Irastorza G, et al : Antiphospholipid syndrome. Lancet 376 : 1498─1509, 2010
5)Kitaori T, et al : Determination of clinically significant tests for antiphospholipid antibodies and cutoff levels for obstetric antiphospholipid syndrome. Lupus 24 : 1505─1519, 2015
6)Lockshin MD, et al : Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 64 : 2311─2318, 2012
7)Clark CA, et al : The lupus anticoagulant : results from 2257 patients attending a high-risk pregnancy clinic. Blood 122 : 341─347, 2013
8)Rai R, et al : Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phopholipid antibodies(or antiphospholipid antibodies). BMJ 314 : 253─257, 1997
9)Kutteh WH : Antiphospholipid antibodies-associated recurrent pregnancy loss : treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174 : 1584─1589, 1996
10)Askie LM, et al : PARIS Collaborative Group : Antiplatelet agents for prevention of pre-eclampsia : a meta-analysis of individual patient data. Lancet 369 : 1791─1798, 2007
11)Sugiura-Ogasawara M, et al : Real-world practice of obstetricians in respect of assays for antiphospholipid antibodies. Mod Rheumatol 25 : 883─887, 2015